Palatin Technologies Inc.
PTN | NASDAQ
$4.85
-$0.08 (-1.62%)
At close: Oct 30, 2026, 3:59 PM ET
$4.80
-$0.05 (-1.03%)
Pre-market:
Nov 2, 2026, 5:57 AM ET
-1.62%
(1D)No price chart data available for 1D timeframe.
Rating
44.2
+6.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #420/1028 (Top 41%)
Key Statistics
Market Data
Market Cap $8.64M
1D Range
4.79 5.11
52W Range
4.77 28.00
Valuation (TTM)
PE -1.02
PB 1.29
EV/EBITDA -0.16
Valuation (NTM)
Forward PE 71.95
Forward PEG -0.21
Price Target $47.50
Cash Flow
FCF Yield -157.3%
SBC Adj. FCF Yield -172.7%
SBC Impact -9.8%
Margins
Gross Margin 99.8%
Operating Margin -65.7%
FCF Margin -103.0%
Growth (CAGR)
Revenue 3Y | 5Y 39.5% |
38.7%
Dil EPS 3Y | 5Y -43.1% |
-7.2%
FCF 3Y | 5Y 40.5% |
16.2%
Returns
ROA -98.3%
ROE -115.0%
ROIC -125.4%
Financial Health
Net Cash
$7.33M
Current Ratio 4.61
Interest Coverage -1,288.77
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is...
Sector Healthcare
Industry Biotechnology
Employees 25
IPO Date Oct 15, 1997
Website palatin.com
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove PTN